Compare MYGN & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYGN | STC |
|---|---|---|
| Founded | 1991 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 2.1B |
| IPO Year | 1996 | 1994 |
| Metric | MYGN | STC |
|---|---|---|
| Price | $4.74 | $64.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $7.64 | ★ $81.33 |
| AVG Volume (30 Days) | ★ 1.6M | 160.8K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.23% |
| EPS Growth | N/A | ★ 55.17 |
| EPS | N/A | ★ 4.05 |
| Revenue | $771,400,000.00 | ★ $2,921,636,000.00 |
| Revenue This Year | $7.19 | $13.62 |
| Revenue Next Year | $5.64 | $7.13 |
| P/E Ratio | ★ N/A | $16.05 |
| Revenue Growth | 2.33 | ★ 17.32 |
| 52 Week Low | $3.76 | $56.39 |
| 52 Week High | $10.30 | $78.61 |
| Indicator | MYGN | STC |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 39.73 |
| Support Level | $3.93 | $59.36 |
| Resistance Level | $5.63 | $64.35 |
| Average True Range (ATR) | 0.35 | 1.92 |
| MACD | 0.01 | -0.37 |
| Stochastic Oscillator | 30.77 | 22.81 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.